Cart
sales@molnova.com
12-Didecanoyl-sn-glycero-3-phosphocholi
CAS No. 3436-44-0
12-Didecanoyl-sn-glycero-3-phosphocholi( 12-Didecanoyl PC | 12-Didecanoyl Phosphatidylcholine )
Catalog No. M19855 CAS No. 3436-44-0
12-Didecanoyl-sn-glycero-3-phosphocholi is a synthetic less hydrophobic phospholipid that has been found to be useful for enhancing the absorption of peptide drugs and hormones such as insulin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name12-Didecanoyl-sn-glycero-3-phosphocholi
-
NoteResearch use only, not for human use.
-
Brief Description12-Didecanoyl-sn-glycero-3-phosphocholi is a synthetic less hydrophobic phospholipid that has been found to be useful for enhancing the absorption of peptide drugs and hormones such as insulin.
-
Description12-Didecanoyl-sn-glycero-3-phosphocholi is a synthetic less hydrophobic phospholipid that has been found to be useful for enhancing the absorption of peptide drugs and hormones such as insulin.
-
In Vitro——
-
In Vivo——
-
Synonyms12-Didecanoyl PC | 12-Didecanoyl Phosphatidylcholine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3436-44-0
-
Formula Weight565.72
-
Molecular FormulaC28H56NO8P
-
Purity>98% (HPLC)
-
SolubilityDMSO: 30 mg/mL
-
SMILESCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Agerholm C et al. Epithelial transport and bioavailability of intranasally administered human growth hormone formulated with the absorption enhancers didecanoyl-L-alpha-phosphatidylcholine and alpha-cyclodextrin in rabbits. J Pharm Sci. 1994 Dec;83(12):1706-11.
molnova catalog
related products
-
JI-101
JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).
-
alpha-Santalen-12-oi...
alpha-Santalen-12-oic acid
-
Lymphocyte Activatin...
Lymphocyte activating pentapeptide is a short peptide sequence found in the Fc region of human IgG1 that has the ability to activate lymphocytes. Lymphocyte activating pentapeptide can be used to study the activation mechanisms of B cells and T cells, and their role in immune responses.
